Yu Cai

9PUBLICATIONS
17CO-AUTHORS
Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunologyHaematologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 15, 2026
Venetoclax-enhanced reduced-intensity conditioning in older patients aged ≥55 years with high-risk myeloid malignancies undergoing allogeneic peripheral blood stem cell transplantation: A phase II study.

|Jul 03, 2024
Azacitidine combined with interferon-α for pre-emptive treatment of AML/MDS after allogeneic peripheral blood stem cell transplantation: A prospective phase II study.

Chongmei Huang, Yannan Jia, Jun Yang

|May 26, 2021
Low-dose antithymocyte globulin plus low-dose posttransplant cyclophosphamide combined with cyclosporine and mycophenolate mofetil for prevention of graft-versus-host disease after HLA-matched unrelated donor peripheral blood stem cell transplantation.

Xi Sun, Jun Yang, Yu Cai

|Dec 06, 2020
Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing.

Jae-Sook Ahn, TaeHyung Kim, Sung-Hoon Jung

|Nov 18, 2018
Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malignancies: a prospective, phase II study.

Jun Yang, Jieling Jiang, Yu Cai

Pageof 2

Frequent Collaborators

6 joint publications

Xianmin Song

2 joint publications

Liping Wan

2 joint publications

Xueying Ding

2 joint publications

Haopeng Wang